GOSSAMER BIO, INC. Shares Outstanding (Cover Page)
GOSSAMER BIO, INC. (GOSS) had Shares Outstanding (Cover Page) of 488.85 million shares as of 2026-08-08, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-08: Entity Common Stock, Shares Outstanding 488.85M shares.
- 2026-05-12: Entity Common Stock, Shares Outstanding 234.70M shares.
- 2026-03-10: Entity Common Stock, Shares Outstanding 234.70M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 231.46M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-08 | 488.85M shares 10-Q · filed 2026-08-13 |
| 2026-05-12 | 234.70M shares 10-Q · filed 2026-05-15 |
| 2026-03-10 | 234.70M shares 10-K · filed 2026-03-17 |
| 2025-10-31 | 231.46M shares 10-Q · filed 2025-11-05 |
| 2025-07-31 | 227.38M shares 10-Q · filed 2025-08-05 |
| 2025-05-12 | 227.30M shares 10-Q · filed 2025-05-15 |
| 2025-03-06 | 227.22M shares 10-K · filed 2025-03-13 |
| 2024-11-04 | 226.60M shares 10-Q · filed 2024-11-07 |
| 2024-08-07 | 226.23M shares 10-Q · filed 2024-08-12 |
| 2024-05-02 | 226.22M shares 10-Q · filed 2024-05-07 |
| 2024-02-27 | 225.58M shares 10-K · filed 2024-03-05 |
| 2023-11-03 | 225.41M shares 10-Q · filed 2023-11-09 |
| 2023-08-03 | 225.32M shares 10-Q · filed 2023-08-08 |
| 2023-05-04 | 95.44M shares 10-Q · filed 2023-05-09 |
| 2023-03-10 | 94.98M shares 10-K · filed 2023-03-17 |
| 2022-10-31 | 94.48M shares 10-Q · filed 2022-11-03 |
| 2022-08-05 | 93.95M shares 10-Q · filed 2022-08-09 |
| 2022-05-05 | 77.12M shares 10-Q · filed 2022-05-10 |
| 2022-02-25 | 76.48M shares 10-K · filed 2022-03-03 |
| 2021-11-04 | 76.46M shares 10-Q · filed 2021-11-08 |
| 2021-08-05 | 75.99M shares 10-Q · filed 2021-08-09 |
| 2021-05-03 | 75.91M shares 10-Q · filed 2021-05-06 |
| 2021-02-19 | 75.53M shares 10-K · filed 2021-02-26 |
| 2020-11-05 | 75.93M shares 10-Q · filed 2020-11-10 |
| 2020-08-06 | 75.83M shares 10-Q · filed 2020-08-11 |
| 2020-05-07 | 66.36M shares 10-Q · filed 2020-05-12 |
| 2020-03-18 | 66.34M shares 10-K · filed 2020-03-24 |
| 2019-11-06 | 66.04M shares 10-Q · filed 2019-11-12 |
| 2019-08-05 | 65.93M shares 10-Q · filed 2019-08-08 |
| 2019-05-08 | 65.89M shares 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 |